A recent article on the Biopharminternational website mentions CMAC being partners in the $29-million Advanced Digital Design of Pharmaceutical Therapeutics (ADDoPT)program, part of the UK's Advanced Manufacturing Supply Chain Initiative.

Edinburgh, Scotland – 2 February, 2016 -- DEM Solutions, the Discrete Element Method (DEM) specialist and market leader, announced it has joined CMAC as a tier 2 industry partner and will provide its EDEM software to integrate into the Centre’s research program.

CMAC is a world class national centre in advanced pharmaceutical manufacturing accelerating the adoption of continuous manufacturing for the production of high-value chemical products to higher quality, at lower cost and more sustainably.

Led by the University of Strathclyde, CMAC is a research platform supported by the EPSRC with teams working across seven UK Universities.  Strong academic and industrial partnerships are the foundation of CMAC with support from Tier 1 industry partners GSK, AstraZeneca, Novartis and Bayer and a broad range of technology companies.

The new partnership with DEM Solutions will enable CMAC to get access to EDEM – one of the leading DEM software for simulation and analysis of bulk solids. EDEM will be used to get a better understanding of how different crystalline pharmaceutical materials behave in both wet and dry conditions, reflecting the environments and processes in which these materials are manufactured. By getting insight into how materials flow and interact when mixed with each other and with processing equipment, researchers can predict properties in advance of expensive R&D to ensure that development workflows are configured to provide the optimal drug product in the most efficient manner possible.

Craig Johnston, CMAC’s Industrial Director, commented:

“We are pleased to welcome DEM Solutions as new tier 2 industry partner. Simulation and modelling tools are key to accelerate development and optimize the design and operation of pharmaceutical manufacturing processes. EDEM software will give us new and fundamental insight into the properties of crystalline materials and their behavior during processing. EDEM will be integrated into our existing in-house digital workflows providing non-DEM-experts with easy access to models and functionality in support of their research.”

Richard LaRoche, CEO of DEM Solutions, added:

“We are delighted to support CMAC’s innovative research program. In the pharmaceutical industry where bulk solids are involved in almost every stage of the manufacturing process, EDEM is a key tool that can model common processes such as mixing, blending, granulation and tablet coating. The insight obtained can lead to optimized processes, innovation in product design as well as reducing the need for physical prototypes and long product development cycles.”

 ###

About DEM Solutions

DEM Solutions is the market leader in Discrete Element Method (DEM) software for bulk material flow simulation. The company's flagship product EDEM^® is used for ‘virtual testing’ of equipment that handles or processes bulk materials in the mining, equipment manufacturing and process industries. Companies worldwide use EDEM to optimize equipment design, increase productivity, reduce costs of operations, shorten product development cycles and drive product innovation.

Founded in 2003, DEM Solutions is a global company headquartered in Edinburgh, UK with offices in USA and Japan and supported by a network of channel partners in South America, South Africa and Asia-Pacific. The Company is chaired by Bryan Taylor and the executive team is Richard LaRoche - Chief Executive, Ian Williamson - Chief Revenue Officer and Gordon Grant - Chief Financial Officer.

For more information visit: http://www.dem-solutions.com/

About CMAC

Established in 2011, CMAC now has 120 staff across its network of 7 leading universities (Strathclyde, Glasgow, Edinburgh, Heriot Watt, Loughborough, Bath, and Cambridge). It conducts leading research in continuous manufacturing with particle focus. EPSRC supports research as a National Centre. CMAC also has significant translational activity including 2 large AMSCI projects. In 2015 CMAC opened its £34m National Facility in Technology Innovation Centre at the University of Strathclyde.

CMAC now has four Tier 1 partners – GSK, AstraZeneca, Novartis and Bayer Healthcare.  In addition to this it has fifteen Tier 2 partners of which DEM Solutions is the newest addition, the others are Siemens, Bayer Technology Services, PwC, Mettler Toledo, Perceptive Engineering, PSE, Booth Welsh, Cambridge Reactor Design, Clairet Scientific Ltd., NiTech, Technobis, Alconbury Weston Ltd., AM Technology, and Sirius Analytical.

For more information visit: http://www.cmac.ac.uk/

Contact Information

Corinne Bossy

Marketing Manager

DEM Solutions

T. +44 (0) 131 220 9840

E: corinne.bossy@dem-solutions.com

Stewart Mitchell

Project Manager

CMAC

T. +44 (0)141 444 7117

E: Stewart.mitchell@strath.ac.uk

There has been a press release this week about ADDoPT. The ADDoPT (Advanced Digital Design of Pharmaceutical Therapeutics) project addresses a key challenge for the pharmaceutical industry; getting new innovative medicines to market in the quickest and most cost-effective way possible to ensure access for patients.CMAC are Specialist knowledge-based partners in this project. For more information please click here.

On 3rd July 2015, Her majesty the Queen Opened the TIC Building at University of Strathclyde. During her visit, the Queen visited the CMAC Labs and was introduced to key people and shown key items of equipment by Academic Director Professor Alastair Florence.

For more information about the Queen's visit to Strathclyde please click here.

CMAC (Continuous Manufacturing and Crystallisation)  featured in Scotsman article by Clive Badman, Industrial Chairman of CMAC. The article describes how CMAC is at the forefront of research into changing the way pharmaceuticals are manufactured. 

To view the article please follow this link.

CMAC board chair Dr Clive Badman, OBE; was interviewed and quoted in part of an article on Pharma Outsourcing in Chemistry World, in June 2014. CMAC and AMSCI are highlighted in the article in the article.

Chemistry World is the print and online magazine of the Royal Society of Chemistry and can be found here.

The article reference: Extance, A., Reaching Out. Chemistry World 2014, 11 (6), 58-92.

Clive Badman, was featured in the Interactive section being interviewed on:
“What are the benefits of working so closely with academia?” where he explains the benfits of how CMAC has brought together universities, 3 Tier 1 companies and SMEs to work together pre-competitively on continuous manufacturing.

The video can be found here. 

Craig Johnston, CMAC Operations Director, was interviewed as the basis of an article in the supplement in the same edition. In the article Craig explains that CMAC is "recognised as a world-leading manufacturing research centre" and that "it will attract inward investment, new jobs and wealth,".

Visit by UK Business Secretary Vince Cable to the EPSRC Centre for Innovative Manufacturing in Continuous Manufacturing and Crystallisation (CMAC) at Strathclyde. Also mentions the University’s Technology Innovation Centre and Fraunhofer Centre. Includes comments from the Principal, Professor Sir Jim McDonald.

Patients could be treated with pills made personally for them in hospitals within a decade, according to scientists at a Scottish university. Read more>>

Patients could soon be treated with personalised pills, custom made for them in hospital, as a result of pioneering work at a Scottish university. Read more >>

PATIENTS could soon be given designer drugs made at their bedside in a move that will save the NHS millions. Scottish scientists have devised a process that will see drugs manufactured in hospitals and tailored to patients’ individual needs. Read more>>

A research centre which it is hoped will revolutionise the way pharmaceuticals are made has been formally opened by UK Business Secretary Vince Cable. The EPSRC Centre for Innovative Manufacturing in Continuous Manufacturing and Crystallisation is bringing together leading academics and industrialists from across the UK to find quicker, more effective and more sustainable ways of manufacturing products. Read more>>

The research centre based at Strathclyde University aims to bring together leading academics and industrialists from across the UK to find more effective ways of manufacturing products. Read more>>

Research projects exploring how light can be used in innovative manufacturing processes and technologies have been awarded £3.6million by The Engineering and Physical Sciences Research Council (EPSRC). Read more>>

£3.6m of funding will be made available to 14 innovative projects exploring laser-guided positioning in pharmaceutical testing, photo chemistry and other light-related processes that could be used in manufacturing. Read the full article here

A research centre which could revolutionise the way pharmaceuticals are made has been formally opened by UK Business Secretary Vince Cable. For video link click here

Business secretary Vince Cable has announced research projects exploring the use of light in innovative manufacturing processes and technologies will receive £3.6 million funding. The funding from The Engineering and Physical Sciences Research Council (EPSRC) was announced by Dr Cable during a tour of laser development company M Squared in Glasgow. Read more

A research centre which it is hoped will revolutionise the way pharmaceuticals are made has been formally opened by UK Business Secretary Vince Cable. The EPSRC Centre for Innovative Manufacturing in Continuous Manufacturing and Crystallisation (CMAC) is bringing together leading academics and industrialists from across the UK to find quicker, more effective and more sustainable ways of manufacturing products. Read more >>

Dr Clive Badman OBE, chair of CMAC board was interviewed for an article in The Manufacturer at the Manufacturing the Future Conferene, Cranfield University. Read the full article here

Centre Director Professor Alastair Florence was interviewed at the Chemspec Europe conference about his experiences with continuous crystallisation. Read the article here.

Cambridge, Manchester, Sheffield and Strathclyde universities and University College London are to get money from the government and companies including Rolls Royce and GlaxoSmithKline. Read more >>

A Scots university-led project aimed at developing cheaper medicines has secured over £34m in funding. Read more >>

Five new university and business partnerships will receive more than £290m of public and private investment in research projects to drive innovation and growth in the UK. Read more >>

Scotland's chemical sciences sector underpins the nation's growth industries...... Read more >>>

Cheaper medicines will be available - and new drugs developed more quickly - following a multi-million pound research project led by the University of Strathclyde in Scotland. Read more >>

A £11.4-million cash injection, supported with £22.8-million industry and charity contributions, was announced today. It will boost the world-class research under way at the Strathclyde-led EPSRC Centre for Innovative Manufacturing in Continuous Manufacturing and Crystallisation (CMAC). Read more >>

UCL's award was announced by the Chancellor George Osborne today and is one of five new university and business partnerships receiving over £290 million of public and private investment in research projects to drive innovation and growth. Read more >>

Five new university and business partnerships are to be given nearly £300 million of public and private investment in research projects. Read more >>

£34M boost for university....

£11 million boost for research....

The University of Strathclyde-led CMAC centre was awarded £11.4m by the Higher Education Funding Council for England (HEFCE). Read more >>

A Scottish university has been given a £34.2 million funding boost to develop new medicines, cheaper drugs and innovative treatments for chronic diseases. Read more >>

Cambridge is at the centre of the Government’s latest initiative to drive innovation and growth in the UK with an injection of £290 million into five research projects. Read more >>

Speaking at the topping-out ceremony of the £700 million Francis Crick Institute in central London today, the chancellor stressed the value of science to the country and economy. Read more >>

Nearly £300 million worth of public and private cash has been awarded to five major science, medical and manufacturing projects across the UK, Read more >>

The EPSRC Centre for Innovative Manufacturing in Continuous Manufacturing and Crystallisation (CMAC) in Strathclyde has received an £11.4 million cash injection from the Higher Education Funding Council for England (HEFCE), supported with £22.8 million industry and charity contributions. Read more >>

Nearly £300m worth of public and private cash has been awarded to five major science, medical and manufacturing projects across the UK including the University of Manchester. Read more >>

Click the link to read all about the latest CMAC published article in the May edition of Speciality Chemicals Magazine, page 50.

The pharmaceutical patent cliff is driving firms to look more closely at improving manufacturing processes.....Read more >>

More hands make less work

CMAC is effectively demonstrating how academic and industry partnership can transform the growth curve....Read more >>